Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2014-10-01
2019-08-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Innovation in Pulmonary Rehabilitation
NCT00123422
Effects of Breathing Retraining in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01175265
Effect of Ventilation-Feedback Training on Exercise Performance in COPD
NCT00037973
The Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD
NCT02099799
Does Pulmonary Rehabilitation Improve Breathing of COPD Patients
NCT01815970
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: The proposed study is a randomized, controlled clinical trial in which 250 patients with moderate-to-severe COPD will be enrolled. One hundred forty of these patients are expected to qualify for randomization into the breathing-retraining plus exercise-training group or the exercise-training alone group. Patients will receive 12-weeks of supervised training according to group assignment (three times weekly) followed by an adherence-intervention program (weekly phone motivational interviews, home-exercise program, and monthly laboratory booster sessions). Follow-up testing will be completed at 12 weeks, and at 6 and 12 months. Testing will include pulmonary function test, incremental-load and constant-load treadmill tests, 6-minute walk test, measurements of dyspnea, assessment of respiratory and quadriceps muscle strength and endurance and quadriceps ultrasonography. Analysis: In the principal analysis of the primary outcome measure (exercise duration; H1) the investigators will compare changes in exercise duration (constant work-rate treadmill test) from baseline to end of study using 2-sample t-test (two-tailed =.05). The primary analysis will be based on intention-to-treat principles. Multiple imputation will be used for study subjects missing the 12-month measurement. This imputation model will be based on baseline characteristics of study participants. Several secondary analyses of the primary outcome measure will be performed (H2-H4). Linear regression will be used to determine whether the observed treatment benefits persist after adjustment for baseline covariates and measures of adherence to treatment. Since several measurements will be taken on each patient, mixed-models analysis will be used to compare the changes on the constant-load treadmill test over time between the two groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
exercise
Patients will exercise for 12 weeks and then participate in an adherence program
Exercise only
Patients will participate in a 12-week exercise program . They will also participate in an adherence program.
exercise plus breathing retraining
Patients will exercise plus breathing retraining for 12 weeks and then participate in an adherence program
Breathing retraining plus exercise
Patients will participate in a 12-week exercise program with breathing retraining. They will also participate in an adherence program.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breathing retraining plus exercise
Patients will participate in a 12-week exercise program with breathing retraining. They will also participate in an adherence program.
Exercise only
Patients will participate in a 12-week exercise program . They will also participate in an adherence program.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* FEV1 \</= 70% predicted
* FEV1/FVC \<70% predicted
* RV/TLC \>/=120%
* SpO2 \>/= 90% at peak exercise (with or without exercise)
* inspiratory capacity decline \>.15L from rest to peak exercise
Exclusion Criteria
* exercise limiting heart disease
* primary asthma
* congestive heart failure
* exercise limiting peripheral arterial disease
* stops exercise due to arthritic pain in the knee or hips
* inability to walk on the treadmill
* pregnancy
* methadone use
* any unforeseen illness or disability that would preclude exercise testing or training
* participation in a formal exercise program within the previous 12 weeks
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eileen G. Collins, PhD RN
Role: PRINCIPAL_INVESTIGATOR
Edward Hines Jr. VA Hospital, Hines, IL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Edward Hines Jr. VA Hospital, Hines, IL
Hines, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
O1325-R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.